Filing Flows › Integrated Biopharma (INBP) › Contract Manufacturing revenue
Integrated Biopharma (INBP) Contract Manufacturing revenue by quarter
Integrated Biopharma's Contract Manufacturing revenue was $9.5M in Q4 FY26 (fourth quarter fiscal 2026), -4% from Q3 FY26. Over the last 7 quarters it ranged from $9.5M (Q4 FY26) to $13.6M (Q4 FY25).
| Quarter | Contract Manufacturing revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q4 FY26 | $9.5M | -4% | -30% |
| Q3 FY26 | $9.8M | -10% | -27% |
| Q2 FY26 | $10.9M | -10% | -6% |
| Q1 FY26 | $12.2M | -10% | — |
| Q4 FY25 | $13.6M | +0.9% | — |
| Q3 FY25 | $13.5M | +15% | — |
| Q2 FY25 | $11.7M | — | — |
Q4 FY26 at a glance
Integrated Biopharma, Q4 FY26: revenue $9.8M (-31% year over year), operating margin -8.9%, net loss $1.4M, operating cash flow −$1.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is Integrated Biopharma's Contract Manufacturing revenue?
Integrated Biopharma's Contract Manufacturing revenue was $9.5M in Q4 FY26 (fourth quarter fiscal 2026), -4% from Q3 FY26.
How has Integrated Biopharma's Contract Manufacturing revenue changed?
Over the last 7 quarters it ranged from $9.5M (Q4 FY26) to $13.6M (Q4 FY25).